Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2/3 1

Status

Terminated 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Plasma cell 1Lymphoid 1Genitourinary 1

Conditions

Prostatic Neoplasms 1Pain, Postoperative 1Pain 1Multiple Myeloma 1Lymphoma 1Agnosia 1

Interventions

Specimen Handling 629pembrolizumab 559Magnetic Resonance Spectroscopy 539Carboplatin 423Cyclophosphamide 371Cisplatin 371Biopsy 357Paclitaxel 304Nivolumab 301Gemcitabine 299Radiotherapy 270Bevacizumab 238Dexamethasone 207fludarabine 205Docetaxel 189durvalumab 178atezolizumab 176Oxaliplatin 172Fluorouracil 167venetoclax 164Rituximab 164Pemetrexed 162Radiation 159Doxorubicin 159Capecitabine 158Radiosurgery 147Etoposide 137Ipilimumab 134Leucovorin 133Lenalidomide 130

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Ketorolac × 90 days × Clear all
NCT05597878 2026-06-01

Opioid-Free Pain Control Regimen Following Robotic Radical Prostatectomy

Wake Forest University Health Sciences

Phase 2/3 Terminated
58 enrolled
Genitourinary

Agnosia, Prostatic Neoplasms

NCT03823534 2026-04-22

Post-Op Pain Control for Prophylactic Intramedullary Nailing.

St. Louis University

Phase 3 Recruiting
60 enrolled
LymphoidPlasma cell

Lymphoma, Multiple Myeloma, Pain, Pain, Postoperative

Data powered by HemOnc (CC BY 4.0) Colophon âš¡